New hope for advanced cancer patients? early trial tests combo therapy
NCT ID NCT05427396
First seen Dec 08, 2025 · Last updated May 21, 2026 · Updated 23 times
Summary
This early-phase study tested a combination of two drugs (JS004 and Toripalimab) in 31 adults with advanced solid tumors like liver, esophageal, stomach, cervical, or colorectal cancer that had stopped responding to standard treatments. The main goal was to check safety and side effects, while also looking at whether the tumors shrank or grew. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER, ESOPHAGEAL SQUAMOUS CELL CARCINOMA, GASTRIC ADENOCARCINOMA, CERVICAL CANCER, MSI-H COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
Conditions
Explore the condition pages connected to this study.